210 related articles for article (PubMed ID: 32489816)
1. Expression of transforming growth factor beta in oral submucous fibrosis.
Rai A; Ahmad T; Parveen S; Parveen S; Faizan MI; Ali S
J Oral Biol Craniofac Res; 2020; 10(2):166-170. PubMed ID: 32489816
[TBL] [Abstract][Full Text] [Related]
2. Salivary transforming growth factor beta in oral submucous fibrosis: A diagnostic and predictive marker.
Rai A; Parveen S; Shree P; Ahmed T; Ali S; Kaur M; Sircar K; Sybil D; Chandra A
J Cancer Res Ther; 2024 Jan; 20(1):275-280. PubMed ID: 38554333
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of transforming growth factor beta1 gene in oral submucous fibrosis induced in Sprague-Dawley rats by injections of areca nut and pan masala (commercial areca nut product) extracts.
Maria S; Kamath VV; Satelur K; Rajkumar K
J Cancer Res Ther; 2016; 12(1):379-85. PubMed ID: 27072267
[TBL] [Abstract][Full Text] [Related]
4. Activation of TGF-β pathway by areca nut constituents: a possible cause of oral submucous fibrosis.
Khan I; Kumar N; Pant I; Narra S; Kondaiah P
PLoS One; 2012; 7(12):e51806. PubMed ID: 23284772
[TBL] [Abstract][Full Text] [Related]
5. Expression of transforming growth factor β and its correlation with lipodystrophy in oral submucous fibrosis: an immunohistochemical study.
Kale AD; Mane DR; Shukla D
Med Oral Patol Oral Cir Bucal; 2013 Jan; 18(1):e12-8. PubMed ID: 22926483
[TBL] [Abstract][Full Text] [Related]
6. Small Molecule "Silmitasertib" Repurposed as Inhibitor of Transforming Growth Factor Beta 1 for the Development of Therapeutics for Oral Submucous Fibrosis.
Boreak N
Biomed Res Int; 2021; 2021():6631848. PubMed ID: 33869629
[TBL] [Abstract][Full Text] [Related]
7. Oral submucous fibrosis: An enigmatic morpho-insight.
Hande AH; Chaudhary MS; Gawande MN; Gadbail AR; Zade PR; Bajaj S; Patil SK; Tekade S
J Cancer Res Ther; 2019; 15(3):463-469. PubMed ID: 31169205
[TBL] [Abstract][Full Text] [Related]
8. Immunoexpression of alpha smooth muscle actin correlates with serum transforming growth factor-β1 levels in oral submucous fibrosis.
Singh I; Juneja S; Tandon A; Jain A; Shetty DC; Sethi A
J Investig Clin Dent; 2019 Nov; 10(4):e12473. PubMed ID: 31631564
[TBL] [Abstract][Full Text] [Related]
9. Transforming growth factor-β1 and TGF-β2 act synergistically in the fibrotic pathway in oral submucous fibrosis: An immunohistochemical observation.
Kamath VV; Krishnamurthy S; Satelur KP; Rajkumar K
Indian J Med Paediatr Oncol; 2015; 36(2):111-6. PubMed ID: 26157288
[TBL] [Abstract][Full Text] [Related]
10. Quantitative estimation of PCNA, c-myc, EGFR and TGF-alpha in oral submucous fibrosis--an immunohistochemical study.
Srinivasan M; Jewell SD
Oral Oncol; 2001 Jul; 37(5):461-7. PubMed ID: 11377235
[TBL] [Abstract][Full Text] [Related]
11. Role of Areca Nut Induced TGF-β and Epithelial-Mesenchymal Interaction in the Pathogenesis of Oral Submucous Fibrosis.
Pant I; Kumar N; Khan I; Rao SG; Kondaiah P
PLoS One; 2015; 10(6):e0129252. PubMed ID: 26107172
[TBL] [Abstract][Full Text] [Related]
12. Dysplastic features relevant to malignant transformation in atrophic epithelium of oral submucous fibrosis: A preliminary study.
Sarode SC; Chaudhary M; Gadbail A; Tekade S; Patil S; Sarode GS
J Oral Pathol Med; 2018 Apr; 47(4):410-416. PubMed ID: 29478271
[TBL] [Abstract][Full Text] [Related]
13. Increased secretion of tissue inhibitors of metalloproteinases 1 and 2 (TIMPs -1 and -2) in fibroblasts are early indicators of oral sub-mucous fibrosis and ageing.
Pitiyage GN; Lim KP; Gemenitzidis E; Teh MT; Waseem A; Prime SS; Tilakaratne WM; Fortune F; Parkinson EK
J Oral Pathol Med; 2012 Jul; 41(6):454-62. PubMed ID: 22385081
[TBL] [Abstract][Full Text] [Related]
14. Expression of Salivary miRNA 21 in Oral Submucous Fibrosis (OSMF): An Observational Study.
Prasad SR; Pai A; Shyamala K; Yaji A
Microrna; 2020; 9(4):295-302. PubMed ID: 31985389
[TBL] [Abstract][Full Text] [Related]
15. Ultrastructural Changes of Collagen in Different Histopathological Grades of Oral Submucous Fibrosis.
Tom A; Baghirath V; Krishna B; Ganepalli A; Kumar JV; Mohan SP
J Pharm Bioallied Sci; 2019 May; 11(Suppl 2):S309-S313. PubMed ID: 31198360
[TBL] [Abstract][Full Text] [Related]
16. Effect of curcumin on the expression of p53, transforming growth factor-β, and inducible nitric oxide synthase in oral submucous fibrosis: A pilot study.
Gupta S; Ghosh S; Gupta S; Sakhuja P
J Investig Clin Dent; 2017 Nov; 8(4):. PubMed ID: 27989010
[TBL] [Abstract][Full Text] [Related]
17. Role of connective tissue growth factor in the pathogenesis of conjunctival scarring in ocular cicatricial pemphigoid.
Razzaque MS; Foster CS; Ahmed AR
Invest Ophthalmol Vis Sci; 2003 May; 44(5):1998-2003. PubMed ID: 12714635
[TBL] [Abstract][Full Text] [Related]
18. Comparative Analysis of Tissue Copper Levels in Oral Submucous Fibrosis (OSMF) Patients.
Srivastava R; Singh DK; Thomas PA; Raza H; Sangamesh NC; Bagde HS
J Pharm Bioallied Sci; 2024 Feb; 16(Suppl 1):S629-S631. PubMed ID: 38595535
[TBL] [Abstract][Full Text] [Related]
19. Molecular profiling of oral squamous cell carcinoma associated with oral submucous fibrosis.
Choudhari S; Masne S; Bhandare P; Dhumal S
J Cancer Res Ther; 2022; 18(1):55-65. PubMed ID: 35381762
[TBL] [Abstract][Full Text] [Related]
20. Transforming growth factor beta isoforms and TGF-βR1 and TGF-βR2 expression in systemic sclerosis patients.
Lomelí-Nieto JA; Muñoz-Valle JF; Baños-Hernández CJ; Navarro-Zarza JE; Godínez-Rubí JM; García-Arellano S; Ramírez-Dueñas MG; Parra-Rojas I; Villanueva-Pérez A; Hernández-Bello J
Clin Exp Med; 2023 Jun; 23(2):471-481. PubMed ID: 35643962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
